Cell Cycle Variants and Metastatic Prostate Cancer Risk
Principal Investigator
Name
Adam Kibel
Degrees
-
Institution
Washington University
Position Title
-
Email
About this CDAS Project
Study
PLCO
(Learn more about this study)
Project ID
2005-0001
Initial CDAS Request Approval
Aug 17, 2005
Title
Cell Cycle Variants and Metastatic Prostate Cancer Risk
Summary
Please see paper application
Aims
Please see paper application
Collaborators
Brian Suarez (WUSM/Psychiatry)
Richard Hayes (NCI, DCEG)
Howard McLeod (WUSM/Pharm)
Kibel Adam (Washington University - School of Medicine)
Robert D. Burk (Albert Einstein College of Medicine)
Tao Wang (Albert Einstein College of Medicine)
William Isaacs (JHMI/Urology)
Yan Yan (WUSM/Urology)
Related Publications
-
Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.
Kibel AS, Ahn J, Isikbay M, Klim A, Wu WS, Hayes RB, Isaacs WB, Daw EW
The Prostate. 2016 Apr; Volume 76 (Issue 5): Pages 479-90 PUBMED